Chesnara Plc: Fourth acquisition in two years
12 November 2026
NeoGenomics, Inc. (NASDAQ: NEO), a leading player in the diagnostics and research industry, offers investors an intriguing opportunity with a striking potential upside of 82.87%. Operating..
10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation in the health information services industry. With its cutting-edge platforms and technologies for analyzing biological..
Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector, has been making waves with its focus on ophthalmic pharmaceutical products. With a market cap..
Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company headquartered in Singapore, is generating significant buzz among investors with its promising pipeline and substantial potential..
Astrana Health Inc. (NASDAQ: ASTH) presents a compelling opportunity for investors in the healthcare sector, particularly those keen on medical care facilities. With a market capitalization..
Progyny, Inc. (NASDAQ: PGNY) is making waves in the healthcare sector with its innovative approach to fertility and family-building benefit solutions. With a market capitalization of..
AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, presents an intriguing case for investors seeking..
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a dynamic player in the biotechnology sector, has been turning heads with its ambitious approach to drug discovery. While the current..
Schrodinger, Inc. (NASDAQ: SDGR), a key player in the healthcare sector, operates within the health information services industry with a unique approach that marries technology and..
Surgery Partners, Inc. (SGRY), a prominent player in the healthcare sector, has caught the attention of investors with its intriguing potential upside of 61.44%, according to..
Investors eyeing opportunities in the biotechnology sector might find Ocular Therapeutix, Inc. (NASDAQ: OCUL) an intriguing prospect, particularly given its compelling analyst ratings and potential upside...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine in oncology, captivating investor interest with a potential upside of 58.03% based on current..
As investors continue to search for compelling opportunities in the healthcare sector, Concentra Group Holdings Parent (CON) stands out with a remarkable potential upside of 29.64%,..
QuidelOrtho Corporation (QDEL), a prominent player in the healthcare sector, is making waves with its diagnostic testing solutions spread across its diversified business units. With a..
Guardian Pharmacy Services, Inc. (GRDN) is carving a niche in the healthcare sector with its innovative approach to serving long-term care facilities (LTCFs) in the United..
Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing investor attention with a substantial potential upside of 49.3%, according to analysts. The company, a key player in..
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out in the biotech industry for its innovative approach to tackling intractable diseases. Headquartered in Pasadena, California, this $7.94 billion..
Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, offers a compelling opportunity for..
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company based in Waltham, Massachusetts, is gaining attention in the investor community due to its impressive growth potential and..
